[HTML][HTML] A potent broadly neutralizing human RSV antibody targets conserved site IV of the fusion glycoprotein
A Tang, Z Chen, KS Cox, HP Su, C Callahan… - Nature …, 2019 - nature.com
Respiratory syncytial virus (RSV) infection is the leading cause of hospitalization and infant
mortality under six months of age worldwide; therefore, the prevention of RSV infection in all …
mortality under six months of age worldwide; therefore, the prevention of RSV infection in all …
A potent broadly neutralizing human RSV antibody targets conserved site IV of the fusion glycoprotein.
A Tang, Z Chen, KS Cox, HP Su… - Nature …, 2019 - search.ebscohost.com
Respiratory syncytial virus (RSV) infection is the leading cause of hospitalization and infant
mortality under six months of age worldwide; therefore, the prevention of RSV infection in all …
mortality under six months of age worldwide; therefore, the prevention of RSV infection in all …
A potent broadly neutralizing human RSV antibody targets conserved site IV of the fusion glycoprotein
A Tang, Z Chen, KS Cox, HP Su… - Nature …, 2019 - econpapers.repec.org
Respiratory syncytial virus (RSV) infection is the leading cause of hospitalization and infant
mortality under six months of age worldwide; therefore, the prevention of RSV infection in all …
mortality under six months of age worldwide; therefore, the prevention of RSV infection in all …
A potent broadly neutralizing human RSV antibody targets conserved site IV of the fusion glycoprotein.
A Tang, Z Chen, KS Cox, HP Su, C Callahan… - Nature …, 2019 - europepmc.org
Respiratory syncytial virus (RSV) infection is the leading cause of hospitalization and infant
mortality under six months of age worldwide; therefore, the prevention of RSV infection in all …
mortality under six months of age worldwide; therefore, the prevention of RSV infection in all …
A potent broadly neutralizing human RSV antibody targets conserved site IV of the fusion glycoprotein
A Tang, Z Chen, KS Cox, HP Su, C Callahan… - Nature …, 2019 - ideas.repec.org
Respiratory syncytial virus (RSV) infection is the leading cause of hospitalization and infant
mortality under six months of age worldwide; therefore, the prevention of RSV infection in all …
mortality under six months of age worldwide; therefore, the prevention of RSV infection in all …
[HTML][HTML] A potent broadly neutralizing human RSV antibody targets conserved site IV of the fusion glycoprotein
A Tang, Z Chen, KS Cox, HP Su, C Callahan… - Nature …, 2019 - ncbi.nlm.nih.gov
Respiratory syncytial virus (RSV) infection is the leading cause of hospitalization and infant
mortality under six months of age worldwide; therefore, the prevention of RSV infection in all …
mortality under six months of age worldwide; therefore, the prevention of RSV infection in all …
A potent broadly neutralizing human RSV antibody targets conserved site IV of the fusion glycoprotein
A Tang, Z Chen, KS Cox, C Callahan, L Zhang… - Nature …, 2019 - elibrary.ru
Respiratory syncytial virus (RSV) infection is the leading cause of hospitalization and infant
mortality under six months of age worldwide; therefore, the prevention of RSV infection in all …
mortality under six months of age worldwide; therefore, the prevention of RSV infection in all …
A potent broadly neutralizing human RSV antibody targets conserved site IV of the fusion glycoprotein
A Tang, Z Chen, KS Cox, HP Su… - Nature …, 2019 - ui.adsabs.harvard.edu
Respiratory syncytial virus (RSV) infection is the leading cause of hospitalization and infant
mortality under six months of age worldwide; therefore, the prevention of RSV infection in all …
mortality under six months of age worldwide; therefore, the prevention of RSV infection in all …
A potent broadly neutralizing human RSV antibody targets conserved site IV of the fusion glycoprotein
A Tang, Z Chen, KS Cox, HP Su… - Nature …, 2019 - pubmed.ncbi.nlm.nih.gov
Respiratory syncytial virus (RSV) infection is the leading cause of hospitalization and infant
mortality under six months of age worldwide; therefore, the prevention of RSV infection in all …
mortality under six months of age worldwide; therefore, the prevention of RSV infection in all …
A potent broadly neutralizing human RSV antibody targets conserved site IV of the fusion glycoprotein.
A Tang, Z Chen, KS Cox, HP Su, C Callahan… - Nature …, 2019 - europepmc.org
Respiratory syncytial virus (RSV) infection is the leading cause of hospitalization and infant
mortality under six months of age worldwide; therefore, the prevention of RSV infection in all …
mortality under six months of age worldwide; therefore, the prevention of RSV infection in all …